|
RCOR3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.971000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.980840E-03 |
| Normal-vs-Stage2 |
2.599200E-03 |
| Normal-vs-Stage3 |
2.599500E-04 |
| Normal-vs-Stage4 |
9.280600E-03 |
| Stage1-vs-Stage2 |
5.457200E-01 |
| Stage1-vs-Stage3 |
2.535400E-01 |
| Stage1-vs-Stage4 |
7.563000E-01 |
| Stage2-vs-Stage3 |
8.197400E-01 |
| Stage2-vs-Stage4 |
8.193200E-01 |
| Stage3-vs-Stage4 |
6.257600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.990900E-04 |
| Normal-vs-AfricanAmerican |
4.428200E-01 |
| Normal-vs-Asian |
1.774070E-02 |
| Caucasian-vs-AfricanAmerican |
9.441600E-02 |
| Caucasian-vs-Asian |
4.499600E-01 |
| AfricanAmerican-vs-Asian |
3.091200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.521800E-03 |
| Normal-vs-Female |
3.955800E-04 |
| Male-vs-Female |
6.880200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.203000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.037390E-03 |
| Normal-vs-Age(61-80Yrs) |
3.079700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.240700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.303000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.552200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.273760E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.358600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.590300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.924500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.319720E-02 |
| Classical-VS-Follicular |
1.962780E-01 |
| Classical-VS-Other |
5.432400E-01 |
| Classical-VS-Normal |
6.798700E-03 |
| Tall-VS-Follicular |
1.344960E-01 |
| Tall-VS-Other |
4.530100E-02 |
| Tall-VS-Normal |
4.06889999999827E-05 |
| Follicular-VS-Other |
3.257000E-01 |
| Follicular-VS-Normal |
1.542250E-03 |
| Other-VS-Normal |
6.146400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.003400E-04 |
| Normal-vs-N1 |
1.275540E-02 |
| N0-vs-N1 |
6.311600E-01 |
|
|
